Sfoglia per Autore
MK-0457: a light at the end of the tunnel?
2007 Martinelli G.; Soverini S.; Iacobucci I.; Baccarani M.
Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Already Harbor Bcr-Abl Kinase Domain Mutations at Low Levels at the Time of Diagnosis - a Report by the GIMEMA ALL Working Party
2008 S. Soverini; G. Martinelli; A. Vitale; A. Gnani; .S Colarossi; S. Paolini; I. Iacobucci; C. Papayannidis; M. Vignetti; A. Lonetti; L. Elia; G Leone; M. Lazzarino; G. Torelli; R. Fanin; G. Cimino; G. Meloni; A. Guarini; F. Mandelli; M. Baccarani; R. Foà
Identification and Molecular Characterization of Two Recurrent Genomic Deletions (Type A and Type B) on 7p12 in IKZF1 Gene in a Large Cohort of BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL): on Behalf of the GIMEMA ALL Working Party
2008 I. Iacobucci; C. T. Storlazzi; E. Ottaviani; A. Lonetti; A. Ferrari; S. Chiaretti; M. Messina; D. Cilloni; N. Testoni; C. Papayannidis; F. Messa; A. Astolfi; L. Impera; A. Vitale; F. Arruga; F. Pane; P. P. Piccaluga; P. D’Addabbo; S. Colarossi; S. Soverini; M. Vignetti; F. Paoloni; S. Paolini; G. Saglio; M. Baccarani; R. Foà; G. Martinelli
HIGH-RESOLUTION GENOMIC PROFILING OF PH-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL) IDENTIFIED RECURRENT COPY NUMBER ANOMALIES IN GENES REGULATING THE CELL CYCLE AND THE B-CELL DIFFERENTIATION
2008 I. Iacobucci; E. Ottaviani; A. Astolfi; T. Storlazzi; N. Testoni; I. Luciana; A. Lonetti; S. Soverini; S. Paolini; P.P. Piccaluga; C. Papayannidis; P. Giannoulia; F. De Rosa; D. Cilloni; F. Messa; A. Pession; F. Pane; A. Vitale; S. Chiaretti; R. Foà; M. Baccarani; G. Martinelli
IKZF1 (IKAROS) DELETIONS ARE A CENTRAL EVENT IN THE PATHOGENESIS OF BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
2008 Iacobucci I; Storlazzi T; Ottaviani E; Lonetti A; Salmi F; Ferrari A; Astolfi A; Testoni N; Impera L; Colarossi S; Baldazzi C; Soverini S; Gnani A; Paolini S; Piccaluga PP; Papayannidis C; Panagiota G; Cilloni D; Messa F; Pane; Vitale A; Chiaretti S; Foà R; Baccarani M; Martinelli G
ACTIVATION-INDUCED CYTIDINE DEAMINASE IS ABERRANTLY OVEREXPRESSED IN BCRABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA CELLS AND PROMOTES DNA-SINGLE STRAND BREAKS
2008 Iacobucci I; Lonetti A;; Ferrari A; Soverini S; Ottaviani E; Testoni N; Colarossi S; Salmi F; Gnani A; Paolini S; Piccaluga PP; Papayannidis C; Panagiota G; Cilloni D; Messa F;; Pane F; Vitale A; Chiaretti S; Saglio G; Foà R; Baccarani M; Martinelli G
What we don’t know about resistance to tyrosine kinase inhibitors in CML: what makes CML cells a tougher enemy than expected?
2008 Martinelli G.; Soverini S.; Iacobucci I.
ALTERNATIVE SPLICING OF IKAROS mRNA IS RESPONSIBLE FOR THE EXPRESSION OF DIFFERENT ABERRANT ISOFORMS IN PHILADELPHIA CHROMOSOME-POSITIVE (PH+) ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL) PATIENTS
2008 A. Lonetti; I. Iacobucci; R. Zuntini; S. Ferrari; D. Cilloni; F. Messa; E. Ottaviani; F. Arruga; F. Salmi; S. Paolini; C. Papayannidis; P.P. Piccaluga; P. Giannoulia; S. Soverini; G. Saglio; F. Pane; A. Vitale; S. Chiaretti; R. Foà; M. Baccarani; G. Martinelli
Farnesyltransferase inhibition in hematologic malignancies: the clinical experience with tipifarnib
2008 Martinelli G; Iacobucci I; Paolini S; Ottaviani E.
Different Isoforms of the B-Cell Mutator Activation-Induced Cytidine Deaminase (AID) Are Aberrantly Over-Expressed in BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL) Patients and Promote Genetic Instability
2008 I. Iacobucci; A. Lonetti; A. Ferrari; S. Soverini; E. Ottaviani; D. Cilloni; S. Chiaretti; N. Testoni; C. Papayannidis; F. Messa; F. Salmi; A. Vitale; Francesca P. Paoloni; F. Arruga; P. Giannoulia; M. Vignetti; F. Pane; P. P. Piccaluga; A. Gnani; S. Paolini; G. Saglio; M. Baccarani; R. Foà; G. Martinelli
Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations
2008 Cilloni D; Messa F; Rosso V; Arruga F; Defilippi I; Carturan S; Catalano R; Pautasso M; Panuzzo C; Nicoli P; Messa E; Morotti A; Iacobucci I; Martinelli G; Bracco E; Saglio G.
Long-term molecular complete remission with IFN-alpha in Ph+ adult acute lymphoid leukemia patients.
2008 Piccaluga PP; Martinelli G; Isidori A; Malagola M; Rondoni M; Paolini S; Amabile M; Iacobucci I; Baccarani M; Visani G.
Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance.
2008 Iacobucci I; Lonetti A; Messa F; Cilloni D; Arruga F; Ottaviani E; Paolini S; Papayannidis C; Piccaluga PP; Giannoulia P; Soverini S; Amabile M; Poerio A; Saglio G; Pane F; Berton G; Baruzzi A; Vitale A; Chiaretti S; Perini G; Foà R; Baccarani M; Martinelli G.
Imatinib mesylate for the treatment of chronic myeloid leukemia.
2008 Soverini S; Martinelli G; Iacobucci I; Baccarani M.
Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, philadelphia-positive chronic myeloid leukemia: the GIMEMA Working Party on CML.
2008 Palandri F; Iacobucci I; Martinelli G; Amabile M; Poerio A; Testoni N; Soverini S; Castagnetti F; De Vivo A; Breccia M; Specchia G; Abruzzese E; Martino B; Cilloni D; Saglio G; Pane F; Liberati AM; Rosti G; Baccarani M; GIMEMA Working Party on CML.
Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method.
2008 Iacobucci I; Lonetti A; Cilloni D; Messa F; Ferrari A; Zuntini R; Ferrari S; Ottaviani E; Arruga F; Paolini S; Papayannidis C; Piccaluga PP; Soverini S; Saglio G; Pane F; Baruzzi A; Vignetti M; Berton G; Vitale A; Chiaretti S; Müschen M; Foà R; Baccarani M; Martinelli G.
New drugs to overcome meccanisms of resistance in Ph+ leukemia: Bosutinib
2008 Martinelli, G.; Iacobucci, I.; Cilloni, D.; Giannoulia, P.; Soverini, S.; Piccaluga, P.P.; Papayannidis, C.; Paolini, S.; Terragna, C.; Amabile, M.; Colarossi, S.; Gnani, A.; Pane, F.; Saglio, G.; Baccarani, M.
Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon-alpha: 5-year outcome
2008 Palandri F, Iacobucci I, Castagnetti F, Testoni N, Poerio A, Amabile M, Breccia M, Intermesoli T, Iuliano F, Rege-Cambrin G, Tiribelli M, Miglino M, Pane F, Saglio G, Martinelli G, Rosti G, Baccarani M; GIMEMA Working Party on CML.
In newly diagnosed chronic phase Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia patients, imatinib-resistant BCR-ABL mutations are already detectable at low levels but do not correlate with subsequent clinical outcome – A study by the GIMEMA ALL and GIMEMA CML Working Parties.
2009 Soverini S; Poerio A; Vitale A; Gnani A; Colarossi S; Castagnetti F; Palandri F; Paolini S; Papayannidis C; Amabile M; Iacobucci I; Lonetti A; Vignetti M; Mandelli F; Baccarani M; Foà R; Martinelli G.
PAX5 GENE IS FREQUENTLY REARRANGED IN A LARGE COHORT OF BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: ON BEHALF OF GIMEMA AL & MDS WP
2009 I. Iacobucci; A. Lonetti; C.T. Storlazzi; A. Ferrari; D. Cilloni;F. Messa; S. Chiaretti; C. Papayannidis; M. Messina; A. Vitale; E. Ottaviani; S. Soverini; A. Astolfi; L. Impera; F. Arruga; P.P. Piccaluga; S. Paolini; M. Baccarani; G. Saglio; F. Pane; R. Foà; G. Martinelli
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
MK-0457: a light at the end of the tunnel? | Martinelli G.; Soverini S.; Iacobucci I.; Baccarani M. | 2007-01-01 | BLOOD | - | 1.04 Replica / breve intervento (e simili) | - |
Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Already Harbor Bcr-Abl Kinase Domain Mutations at Low Levels at the Time of Diagnosis - a Report by the GIMEMA ALL Working Party | S. Soverini; G. Martinelli; A. Vitale; A. Gnani; .S Colarossi; S. Paolini; I. Iacobucci; C. Papay...annidis; M. Vignetti; A. Lonetti; L. Elia; G Leone; M. Lazzarino; G. Torelli; R. Fanin; G. Cimino; G. Meloni; A. Guarini; F. Mandelli; M. Baccarani; R. Foà | 2008-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
Identification and Molecular Characterization of Two Recurrent Genomic Deletions (Type A and Type B) on 7p12 in IKZF1 Gene in a Large Cohort of BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL): on Behalf of the GIMEMA ALL Working Party | I. Iacobucci; C. T. Storlazzi; E. Ottaviani; A. Lonetti; A. Ferrari; S. Chiaretti; M. Messina; D.... Cilloni; N. Testoni; C. Papayannidis; F. Messa; A. Astolfi; L. Impera; A. Vitale; F. Arruga; F. Pane; P. P. Piccaluga; P. D’Addabbo; S. Colarossi; S. Soverini; M. Vignetti; F. Paoloni; S. Paolini; G. Saglio; M. Baccarani; R. Foà; G. Martinelli | 2008-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
HIGH-RESOLUTION GENOMIC PROFILING OF PH-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL) IDENTIFIED RECURRENT COPY NUMBER ANOMALIES IN GENES REGULATING THE CELL CYCLE AND THE B-CELL DIFFERENTIATION | I. Iacobucci; E. Ottaviani; A. Astolfi; T. Storlazzi; N. Testoni; I. Luciana; A. Lonetti; S. Sove...rini; S. Paolini; P.P. Piccaluga; C. Papayannidis; P. Giannoulia; F. De Rosa; D. Cilloni; F. Messa; A. Pession; F. Pane; A. Vitale; S. Chiaretti; R. Foà; M. Baccarani; G. Martinelli | 2008-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
IKZF1 (IKAROS) DELETIONS ARE A CENTRAL EVENT IN THE PATHOGENESIS OF BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA | Iacobucci I; Storlazzi T; Ottaviani E; Lonetti A; Salmi F; Ferrari A; Astolfi A; Testoni N; Imper...a L; Colarossi S; Baldazzi C; Soverini S; Gnani A; Paolini S; Piccaluga PP; Papayannidis C; Panagiota G; Cilloni D; Messa F; Pane; Vitale A; Chiaretti S; Foà R; Baccarani M; Martinelli G | 2008-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
ACTIVATION-INDUCED CYTIDINE DEAMINASE IS ABERRANTLY OVEREXPRESSED IN BCRABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA CELLS AND PROMOTES DNA-SINGLE STRAND BREAKS | Iacobucci I; Lonetti A;; Ferrari A; Soverini S; Ottaviani E; Testoni N; Colarossi S; Salmi F; Gna...ni A; Paolini S; Piccaluga PP; Papayannidis C; Panagiota G; Cilloni D; Messa F;; Pane F; Vitale A; Chiaretti S; Saglio G; Foà R; Baccarani M; Martinelli G | 2008-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
What we don’t know about resistance to tyrosine kinase inhibitors in CML: what makes CML cells a tougher enemy than expected? | Martinelli G.; Soverini S.; Iacobucci I. | 2008-01-01 | CLINICAL LEUKEMIA | - | 1.01 Articolo in rivista | - |
ALTERNATIVE SPLICING OF IKAROS mRNA IS RESPONSIBLE FOR THE EXPRESSION OF DIFFERENT ABERRANT ISOFORMS IN PHILADELPHIA CHROMOSOME-POSITIVE (PH+) ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL) PATIENTS | A. Lonetti; I. Iacobucci; R. Zuntini; S. Ferrari; D. Cilloni; F. Messa; E. Ottaviani; F. Arruga; ...F. Salmi; S. Paolini; C. Papayannidis; P.P. Piccaluga; P. Giannoulia; S. Soverini; G. Saglio; F. Pane; A. Vitale; S. Chiaretti; R. Foà; M. Baccarani; G. Martinelli | 2008-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
Farnesyltransferase inhibition in hematologic malignancies: the clinical experience with tipifarnib | Martinelli G; Iacobucci I; Paolini S; Ottaviani E. | 2008-01-01 | CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | - | 1.01 Articolo in rivista | - |
Different Isoforms of the B-Cell Mutator Activation-Induced Cytidine Deaminase (AID) Are Aberrantly Over-Expressed in BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL) Patients and Promote Genetic Instability | I. Iacobucci; A. Lonetti; A. Ferrari; S. Soverini; E. Ottaviani; D. Cilloni; S. Chiaretti; N. Tes...toni; C. Papayannidis; F. Messa; F. Salmi; A. Vitale; Francesca P. Paoloni; F. Arruga; P. Giannoulia; M. Vignetti; F. Pane; P. P. Piccaluga; A. Gnani; S. Paolini; G. Saglio; M. Baccarani; R. Foà; G. Martinelli | 2008-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations | Cilloni D; Messa F; Rosso V; Arruga F; Defilippi I; Carturan S; Catalano R; Pautasso M; Panuzzo C...; Nicoli P; Messa E; Morotti A; Iacobucci I; Martinelli G; Bracco E; Saglio G. | 2008-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
Long-term molecular complete remission with IFN-alpha in Ph+ adult acute lymphoid leukemia patients. |
Piccaluga PP; Martinelli G; Isidori A; Malagola M; Rondoni M; Paolini S; Amabile M; Iacobucci I;... Baccarani M; Visani G. |
2008-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance. | Iacobucci I; Lonetti A; Messa F; Cilloni D; Arruga F; Ottaviani E; Paolini S; Papayannidis C; Pic...caluga PP; Giannoulia P; Soverini S; Amabile M; Poerio A; Saglio G; Pane F; Berton G; Baruzzi A; Vitale A; Chiaretti S; Perini G; Foà R; Baccarani M; Martinelli G. | 2008-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
Imatinib mesylate for the treatment of chronic myeloid leukemia. | Soverini S; Martinelli G; Iacobucci I; Baccarani M. | 2008-01-01 | EXPERT REVIEW OF ANTICANCER THERAPY | - | 1.01 Articolo in rivista | - |
Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, philadelphia-positive chronic myeloid leukemia: the GIMEMA Working Party on CML. | Palandri F; Iacobucci I; Martinelli G; Amabile M; Poerio A; Testoni N; Soverini S; Castagnetti F;... De Vivo A; Breccia M; Specchia G; Abruzzese E; Martino B; Cilloni D; Saglio G; Pane F; Liberati AM; Rosti G; Baccarani M; GIMEMA Working Party on CML. | 2008-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method. |
Iacobucci I; Lonetti A; Cilloni D; Messa F; Ferrari A; Zuntini R; Ferrari S; Ottaviani E; Arruga... F; Paolini S; Papayannidis C; Piccaluga PP; Soverini S; Saglio G; Pane F; Baruzzi A; Vignetti M; Berton G; Vitale A; Chiaretti S; Müschen M; Foà R; Baccarani M; Martinelli G. |
2008-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
New drugs to overcome meccanisms of resistance in Ph+ leukemia: Bosutinib | Martinelli, G.; Iacobucci, I.; Cilloni, D.; Giannoulia, P.; Soverini, S.; Piccaluga, P.P.; Papaya...nnidis, C.; Paolini, S.; Terragna, C.; Amabile, M.; Colarossi, S.; Gnani, A.; Pane, F.; Saglio, G.; Baccarani, M. | 2008-01-01 | HEMATOLOGY MEETING REPORTS | - | 4.01 Contributo in Atti di convegno | - |
Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon-alpha: 5-year outcome | Palandri F, Iacobucci I, Castagnetti F, Testoni N, Poerio A, Amabile M, Breccia M, Intermesoli T,... Iuliano F, Rege-Cambrin G, Tiribelli M, Miglino M, Pane F, Saglio G, Martinelli G, Rosti G, Baccarani M; GIMEMA Working Party on CML. | 2008-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
In newly diagnosed chronic phase Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia patients, imatinib-resistant BCR-ABL mutations are already detectable at low levels but do not correlate with subsequent clinical outcome – A study by the GIMEMA ALL and GIMEMA CML Working Parties. | Soverini S; Poerio A; Vitale A; Gnani A; Colarossi S; Castagnetti F; Palandri F; Paolini S; Papay...annidis C; Amabile M; Iacobucci I; Lonetti A; Vignetti M; Mandelli F; Baccarani M; Foà R; Martinelli G. | 2009-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
PAX5 GENE IS FREQUENTLY REARRANGED IN A LARGE COHORT OF BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: ON BEHALF OF GIMEMA AL & MDS WP | I. Iacobucci; A. Lonetti; C.T. Storlazzi; A. Ferrari; D. Cilloni;F. Messa; S. Chiaretti; C. Papay...annidis; M. Messina; A. Vitale; E. Ottaviani; S. Soverini; A. Astolfi; L. Impera; F. Arruga; P.P. Piccaluga; S. Paolini; M. Baccarani; G. Saglio; F. Pane; R. Foà; G. Martinelli | 2009-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile